-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...

The FDA has approved the expanded use of Botox® (onabotulinumtoxinA; Allergan) for the treatment of spasticity in pediatric patients aged ≥2 years, including those with lower limb spasticity caused by ...

(RTTNews) - Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration approved a supplemental Biologics License Application or sBLA that supports expanded use of BOTOX for ...

Allergan announced that the Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Applications (sBLAs) for Botox (onabotulinumtoxinA) injection for the ...

The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the treatment of upper limb spasticity in adults, according to a press release. Botox ...

Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...

NEW YORK, May 26 (Reuters) - Allergan Inc said on Tuesday that U.S. health regulators will require more information before approving its Botox anti-wrinkle drug as a treatment for upper limb ...

Just before Christmas 2013, 49-year-old David Brongiel's life was forever changed by a motor vehicle accident that resulted in a severe traumatic brain injury, or TBI. A TBI occurs following a violent ...

HOUSTON – Almost half of stroke survivors can experience spasticity, meaning their muscles get tighter and tighter until they lose the ability to move. RELATED: How one program is helping brain trauma ...

Botulinum neurotoxin (BoNT) injections have emerged as a cornerstone treatment for a range of neuromuscular conditions, from dystonia and spasticity to aesthetic muscle contouring. Advances in imaging ...